FDA announces Medical Device & Generic Drug Fees
On August 2 the Food & Drug Adminstration (FDA) announced the 2022 Medical Device User Fee Amendments (MDUFA) user fee rates (click here), the 2.5% increase is quite a bit less compared to the 7% hike instituted last year. The fees for a premarket submission received by the FDA during this year will apply from October 1, 2021, through September 30, 2022. All facilities must pay the fee to be considered in good standing with the FDA.
Compliance Insight’s experts in Medical Device Regulations understand the nuances of international and domestic FDA Medical Device Regulations and possess the expertise needed to bring your product to market. Click here to learn more!
|Application Type||Standard Fee||Small Business Fee†|
|De Novo Classification Request||$112,457||$28,114|
|BLA Efficacy Supplement||$374,858||$93,714|
|Annual Fee for Periodic Reporting on a Class III device (PMAs,PDPs, and PMRs)||$13,120||$3,280|